Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Total Liabilities (2010 - 2026)

Analysis

Cerenome (CNSY) Total Liabilities (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn 1.62 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.41 Bn 44.41 Bn - 1.72 Bn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 10.03 Bn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 1.35 Bn
10 Cerenome 20.42 Mn 11.83 Mn - 8.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.57 Mn
Mar 31, 2026 7.96 Mn
Dec 31, 2025 12.33 Mn
Sep 30, 2025 13.62 Mn
Jun 30, 2025 7.32 Mn
Mar 31, 2025 35.70 Mn
Dec 31, 2024 15.58 Mn
Sep 30, 2024 12.15 Mn
Jun 30, 2024 18.84 Mn
Mar 31, 2024 10.46 Mn
Dec 31, 2023 12.74 Mn
Sep 30, 2023 10.66 Mn
Jun 30, 2023 11.54 Mn
Mar 31, 2023 12.96 Mn
Dec 31, 2022 17.42 Mn
Sep 30, 2022 11.70 Mn
Jun 30, 2022 11.59 Mn
Mar 31, 2022 9.87 Mn
Dec 31, 2021 11.15 Mn
Sep 30, 2021 10.00 Mn